NEW YORK (GenomeWeb) – The University of Twente announced today that its Health, Technology and Services Research department has formed a collaboration with the Luxembourg Institute of Health and the University of York to investigate the clinical and economic challenges of personalized medicine.
The research effort, which has a €1.7 million ($1.9 million) budget over four years, will focus on personalized medicine in cancer, diabetes, cardiovascular disorders, and rheumatic disease, according to the University of Twente. As part of the effort, the three institutions aim to recruit additional Ph.D.'s, post-doctoral students, and staff.
As part of the collaboration, the University of Twente aims to develop a program in translational research, which will include the early modeling and economic evaluation of molecular diagnostic technologies, including circulating tumor cells, cell-free DNA biomarkers, other molecular biomarkers, and eventually whole-genome sequencing, it said.